<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Clinical Utility Gene Card for: Fibrodysplasia ossificans progressiva</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
				<date type="published" when="2015-01-21">21 January 2015</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Nathalie</forename><surname>Bravenboer</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Departments of Clinical Genetics</orgName>
								<orgName type="department" key="dep2">Clinical Chemistry and Internal Medicine</orgName>
								<orgName type="institution">VU University Medical Center</orgName>
								<address>
									<settlement>Amsterdam</settlement>
									<country key="NL">The Netherlands</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Dimitra</forename><surname>Micha</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Departments of Clinical Genetics</orgName>
								<orgName type="department" key="dep2">Clinical Chemistry and Internal Medicine</orgName>
								<orgName type="institution">VU University Medical Center</orgName>
								<address>
									<settlement>Amsterdam</settlement>
									<country key="NL">The Netherlands</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">James</forename><forename type="middle">T</forename><surname>Triffit</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Botnar Research Centre</orgName>
								<orgName type="institution">University of Oxford</orgName>
								<address>
									<settlement>Oxford</settlement>
									<country key="GB">UK</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Alex</forename><forename type="middle">N</forename><surname>Bullock</surname></persName>
							<affiliation key="aff2">
								<orgName type="department">Structural Genomics Consortium</orgName>
								<orgName type="institution">University of Oxford</orgName>
								<address>
									<settlement>Oxford</settlement>
									<country key="GB">UK</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Roberto</forename><surname>Ravazollo</surname></persName>
							<affiliation key="aff3">
								<orgName type="department" key="dep1">Department of Neusoscience</orgName>
								<orgName type="department" key="dep2">Genetics, Maternal and Child Health</orgName>
								<orgName type="institution">University of Genova and CEBR</orgName>
								<address>
									<settlement>Rehabilitation, Genova</settlement>
									<region>Ophthalmology</region>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Renata</forename><surname>Bocciardi</surname></persName>
							<affiliation key="aff4">
								<orgName type="department" key="dep1">Department of Pediatrics</orgName>
								<orgName type="department" key="dep2">Unit of Rare Diseases</orgName>
								<orgName type="institution">Gaslini Institute</orgName>
								<address>
									<settlement>Genoa</settlement>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Maja</forename><surname>Di Rocco</surname></persName>
							<affiliation key="aff4">
								<orgName type="department" key="dep1">Department of Pediatrics</orgName>
								<orgName type="department" key="dep2">Unit of Rare Diseases</orgName>
								<orgName type="institution">Gaslini Institute</orgName>
								<address>
									<settlement>Genoa</settlement>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">J</forename><forename type="middle">Coen</forename><surname>Netelenbos</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Departments of Clinical Genetics</orgName>
								<orgName type="department" key="dep2">Clinical Chemistry and Internal Medicine</orgName>
								<orgName type="institution">VU University Medical Center</orgName>
								<address>
									<settlement>Amsterdam</settlement>
									<country key="NL">The Netherlands</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Peter</forename><forename type="middle">Ten</forename><surname>Dijke</surname></persName>
							<affiliation key="aff5">
								<orgName type="department" key="dep1">Department of Molecular Cell Biology</orgName>
								<orgName type="department" key="dep2">Cancer Genomics Centre Netherlands and Centre for Biomedical Genetics</orgName>
								<orgName type="institution">Leiden University Medical Center</orgName>
								<address>
									<settlement>Leiden</settlement>
									<country key="NL">The Netherlands</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Gonzalo</forename><surname>Sánchez-Duffhues</surname></persName>
							<affiliation key="aff5">
								<orgName type="department" key="dep1">Department of Molecular Cell Biology</orgName>
								<orgName type="department" key="dep2">Cancer Genomics Centre Netherlands and Centre for Biomedical Genetics</orgName>
								<orgName type="institution">Leiden University Medical Center</orgName>
								<address>
									<settlement>Leiden</settlement>
									<country key="NL">The Netherlands</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Fred</forename><forename type="middle">S</forename><surname>Kaplan</surname></persName>
							<affiliation key="aff6">
								<orgName type="department" key="dep1">The Center for Research in FOP and Related Disorders</orgName>
								<orgName type="department" key="dep2">The Perelman School of Medicine</orgName>
								<orgName type="institution">University of Pennsylvania</orgName>
								<address>
									<settlement>Philadelphia</settlement>
									<region>PA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Eileen</forename><forename type="middle">M</forename><surname>Shore</surname></persName>
							<affiliation key="aff6">
								<orgName type="department" key="dep1">The Center for Research in FOP and Related Disorders</orgName>
								<orgName type="department" key="dep2">The Perelman School of Medicine</orgName>
								<orgName type="institution">University of Pennsylvania</orgName>
								<address>
									<settlement>Philadelphia</settlement>
									<region>PA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Robert</forename><forename type="middle">J</forename><surname>Pignolo</surname></persName>
							<affiliation key="aff6">
								<orgName type="department" key="dep1">The Center for Research in FOP and Related Disorders</orgName>
								<orgName type="department" key="dep2">The Perelman School of Medicine</orgName>
								<orgName type="institution">University of Pennsylvania</orgName>
								<address>
									<settlement>Philadelphia</settlement>
									<region>PA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Petra</forename><surname>Seemann</surname></persName>
							<affiliation key="aff7">
								<orgName type="department">Berlin Brandenburg Center for Regenerative Therapies (BCRT)</orgName>
								<orgName type="institution">Charité-Universitätsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Francesc</forename><surname>Ventura</surname></persName>
							<affiliation key="aff8">
								<orgName type="department">Departament de Ciències Fisiològiques II</orgName>
								<orgName type="institution" key="instit1">Universitat de Barcelona</orgName>
								<orgName type="institution" key="instit2">IDIBELL, L&apos;Hospitalet de Llobregat</orgName>
								<address>
									<settlement>Barcelona</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Genevieve</forename><surname>Beaujat</surname></persName>
							<affiliation key="aff9">
								<orgName type="department">Département de Génétique</orgName>
								<orgName type="institution" key="instit1">Centre de Référence Maladies Osseuses Constitutionnelles</orgName>
								<orgName type="institution" key="instit2">Hôpital Necker-Enfants malades</orgName>
								<address>
									<settlement>Paris</settlement>
									<country key="FR">France</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Elizabeth</forename><forename type="middle">M W</forename><surname>Eekhoff</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Departments of Clinical Genetics</orgName>
								<orgName type="department" key="dep2">Clinical Chemistry and Internal Medicine</orgName>
								<orgName type="institution">VU University Medical Center</orgName>
								<address>
									<settlement>Amsterdam</settlement>
									<country key="NL">The Netherlands</country>
								</address>
							</affiliation>
						</author>
						<author role="corresp">
							<persName><forename type="first">Gerard</forename><surname>Pals</surname></persName>
							<email>g.pals@vumc.nl</email>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Departments of Clinical Genetics</orgName>
								<orgName type="department" key="dep2">Clinical Chemistry and Internal Medicine</orgName>
								<orgName type="institution">VU University Medical Center</orgName>
								<address>
									<settlement>Amsterdam</settlement>
									<country key="NL">The Netherlands</country>
								</address>
							</affiliation>
							<affiliation key="aff10">
								<orgName type="department" key="dep1">Correspondence: Dr G Pals</orgName>
								<orgName type="department" key="dep2">Department Clinical Genetics</orgName>
								<orgName type="institution">VU University Medical Center</orgName>
								<address>
									<settlement>Amsterdam</settlement>
									<country key="NL">The Netherlands</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Clinical Utility Gene Card for: Fibrodysplasia ossificans progressiva</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2015-01-21">21 January 2015</date>
						</imprint>
					</monogr>
					<idno type="MD5">92CB4AB37E06F535FC2243152E790B52</idno>
					<idno type="DOI">10.1038/ejhg.2014.274</idno>
					<note type="submission">Received 19 August 2014; revised 3 November 2014; accepted 16 November 2014;</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:39+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Fibrodysplasia ossificans progressiva (FOP), Myositis ossificans progressiva.</s></p><p><s>1.2 OMIM# of the disease 135100.</s></p><p><s><ref type="bibr" target="#b2">[3]</ref> 1.4 OMIM# of the gene(s) 102576.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="1.5">Mutational spectrum</head><p><s>The spectrum described in this paragraph is based on RefSeq NM_001105.4.</s></p><p><s>All patients have heterozygous ACVR1 missense mutations in conserved amino acids.</s><s>This disease-causing variant is a de novo mutation and therefore referred to as a mutation.</s></p><p><s>Patients with classic clinical features of FOP (great toe malformations and progressive heterotopic ossification) have previously been found to carry the same heterozygous mutation (c.617G4A; p. (Arg206His)) in the ACVR1 gene leading to an over-activation of the BMP signalling pathway.</s><s>Only recently a new heterozygous ACVR1 mutation at codon 207 (c.619C4G, p.(Gln207Glu)) located in a codon adjacent to the c.617G4A, p.(Arg206His) of the ACVR1 was reported in two FOP patients with the classical phenotype. <ref type="bibr" target="#b3">4</ref></s><s>mong patients with FOP-like heterotopic ossification and/or toe malformation, there are patients with clinical features unusual for FOP.</s><s>These atypical FOP patients form two classes: FOP-plus (classic defining features of FOP plus one or more atypical features, predominantly associated with the classical p.(Arg206His) mutation</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>and FOP variants (major variations in one or both of the two classic defining features of FOP, associated with non-Arg206His mutations within the ACVR1 receptor).</s><s>5]<ref type="bibr" target="#b5">[6]</ref> A public list of disease causing variants is not available yet.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="1.6">Analytical methods</head><p><s>DNA sequence analysis of protein-coding exons and splice junctions. <ref type="bibr" target="#b1">2</ref></s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="1.7">Analytical validation</head><p><s>When a new mutation is found, functional testing will be necessary, like a BMP reporter assay.</s></p><p><s>1.8 Estimated frequency of the disease (incidence disease at birth ('birth prevalence') or population prevalence)</s></p><p><s>1:2 000 000. <ref type="bibr" target="#b4">5</ref> 1.9</s><s>If applicable, prevalence in the ethnic group of investigated person:</s></p><p><s>No ethical, racial, gender or geographic prediliction. <ref type="bibr" target="#b4">5</ref></s><s>10 Diagnostic setting:</s></p><formula xml:id="formula_0">Yes No A. (Differential) diagnostics ⊠ □ B. Predictive testing □ ⊠ C. Risk assessment in relatives ⊠ □ D. Prenatal ⊠ □</formula><p><s>7]<ref type="bibr" target="#b7">[8]</ref> There are at least three other forms of MO of which the pathology is largely unknown, including MO Circumscripta, characterized by dystrophic calcification generally following severe trauma leading to heterotopic ossifications of a single intramuscular connective tissue, MO pseudo-malignant, which is limited to soft tissue and is not associated to any trauma, and a MO associated with paraplegia, closed head injury or severe trauma (non-hereditary heterotopic ossification). <ref type="bibr" target="#b6">7,</ref><ref type="bibr" target="#b8">9</ref></s><s>POH is characterized by progressive ossification of cutaneous, subcutaneous, and deep connective tissues and caused by an inactivation of GNAS in most cases. <ref type="bibr" target="#b9">10</ref></s><s>In early stages misdiagnosis, aggressive fibromatosis or sarcoma may be suspected.</s></p><p><s>Comment: ad C: Risk assessment in first generation relatives, including brothers and sisters, could be considered due to a socalled 'variant FOP' presenting with normal great toes and late-onset heterotopic ossification <ref type="bibr" target="#b10">11</ref> or when one of the parents has a germ line mosaicism. <ref type="bibr" target="#b11">12</ref></s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.">TEST CHARACTERISTICS</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.3">Clinical sensitivity (proportion of positive tests if the disease is present)</head><p><s>The clinical sensitivity can be dependent on variable factors such as age or family history.</s><s>In such cases a general statement should be given, even if a quantification can only be made case by case.</s><s>100%. <ref type="bibr" target="#b1">2</ref></s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.4">Clinical specificity (proportion of negative tests if the disease is not present)</head><p><s>The clinical specificity can be dependent on variable factors such as age or family history.</s><s>In such cases a general statement should be given, even if a quantification can only be made case by case.</s><s>100%. <ref type="bibr" target="#b1">2</ref> 2.5 Positive clinical predictive value (life-time risk to develop the disease if the test is positive) 100%, although we are aware of few rare cases of FOP with negligible progression.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.6">Negative clinical predictive value (probability not to develop the disease if the test is negative).</head><p><s>If the index case in the family has been tested positive for a causative mutation:</s></p><p><s>100%.</s><s>If the index case in the family has not been tested: Assume an increased risk based on family history for a non-affected person.</s><s>Allelic and locus heterogeneity may need to be considered.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.">CLINICAL UTILITY</head><p><s>3.1 (Differential) diagnostics: The tested person is clinically affected (To be answered if in 1.10 'A' was marked)</s></p><p><s>100% in the classical mutation, although there is a clinical variability/expressivity.</s><s>A diagnosis based on clinical findings (malformed great toes in association with either soft tissue swelling or heterotopic ossification in characteristic anatomic patterns could be made by very experienced doctors, <ref type="bibr" target="#b13">14</ref> but in approximately 87% there is a long delay before awareness or before the appropriate diagnosis has been established. <ref type="bibr" target="#b10">11,</ref><ref type="bibr" target="#b14">15</ref></s><s>1.2</s><s>Describe the burden of alternative diagnostic methods to the patient No alternative affirmative methods are available.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.1.3">How is the cost effectiveness of alternative diagnostic methods to be judged?</head><p><s>No alternative affirmative methods are available.</s></p><p><s>On the basis of the clinical and radiologic findings the diagnosis of FOP can be highly suspected, even prior to heterotopic ossifications.</s><s>Characteristic toe malformations and cervical spine fusions may be diagnosed by X-ray.</s><s>However, because FOP is infrequently seen by most clinicians and onset of progressive heterotopic ossification may be variable in the first decade of life, clinical misdiagnosis is common. <ref type="bibr" target="#b13">14,</ref><ref type="bibr" target="#b14">15</ref></s><s>1.4</s><s>Will disease management be influenced by the result of a genetic test?</s></p><formula xml:id="formula_1">No □ Yes ⊠ Therapy (please describe)</formula><p><s>None at the moment, but in the future some drugs might have different effects on the classical mutation or the other ACVR1 mutations.</s><s>Current treatment options are only palliative and symptom-modifying.</s><s>Prevention of soft tissue injury and protection against the influenza virus remain a hallmark of FOP management. <ref type="bibr" target="#b15">16</ref></s><s>ognosis (please describe)</s></p><p><s>The prognosis varies largely and depends on clinical course and severity.</s><s>FOP is not only an extremely disabling disease but also a condition of shortened lifespan.</s><s>The median age of the time of death is 40 years.</s><s><ref type="bibr" target="#b18">[19]</ref> Management (please describe)</s></p><p><s>Paediatricians should be aware of the early diagnostic features of fibrodysplasia ossificans progressiva, even before the appearance of heterotopic ossification.</s><s>This awareness should prompt early genetic consultation and testing and the institution of assiduous precautions to prevent iatrogenic harm. <ref type="bibr" target="#b13">14,</ref><ref type="bibr" target="#b14">15</ref></s><s>Intramuscular injections, biopsies, and surgical procedures as well as injuries with soft tissue trauma can also result in exacerbation and should be avoided.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.2">Predictive setting:</head><p><s>The tested person is clinically unaffected but carries an increased risk based on family history (To be answered if in 1.10 'B' was marked)</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.4">Prenatal diagnosis (To be answered if in 1.10 'D' was marked)</head><p><s>Prenatal diagnosis should only be done for FOP patients (they have 50% risk to transmit the disease) or for parents of FOP patients, if they expect new children (risk of mosaicism in an unaffected parent). <ref type="bibr" target="#b11">12</ref></s><s>4.1 Does a positive genetic test result in the index patient enable a prenatal diagnosis?</s><s>Yes, although rare, up to three successive generations of transmissions of FOP have been described.</s><s><ref type="bibr" target="#b19">20</ref></s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="4.">IF APPLICABLE, FURTHER CONSEQUENCES OF TESTING</head><p><s>Please assume that the result of a genetic test has no immediate medical consequences.</s><s>Is there any evidence that a genetic test is nevertheless useful for the patient or his/her relatives?</s><s>(Please describe) NA.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>CONFLICT OF INTEREST</head><p><s>The authors declare no conflict of interest.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>1</head><label>1</label><figDesc><div><p></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>3. 1 . 1</head><label>11</label><figDesc><div><p><s>Can a diagnosis be made other than through a genetic test?</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head></head><label></label><figDesc><div><p><s>3.2.1 Will the result of a genetic test influence lifestyle and prevention?If the test result is positive (please describe): see 3.1.4prognosis.If the test result is negative (please describe): based on current knowledge no risk.3.2.2 Which options in view of lifestyle and prevention does a person at-risk have if no genetic test has been done (please describe)?The lifestyle and prevention will be the same in patients with a clinical diagnosis, but with or without a genetic diagnosis.3.3Genetic</s><s>risk assessment in family members of a diseased person(To be answered if in 1.10 'C' was marked)</s></p></div></figDesc><table><row><cell>3.3.1 Does the result of a genetic test resolve the genetic situation in</cell></row><row><cell>that family?</cell></row><row><cell>Yes.</cell></row><row><cell>3.3.2 Can a genetic test in the index patient save genetic or other tests</cell></row><row><cell>in family members?</cell></row><row><cell>Yes (if negative).</cell></row><row><cell>3.3.3 Does a positive genetic test result in the index patient enable a</cell></row><row><cell>predictive test in a family member?</cell></row><row><cell>Yes.</cell></row></table></figure>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>ACKNOWLEDGEMENTS</head><p><s>This work was supported by ZonMw, EuroGentest2 (Unit 2: 'Genetic testing as part of health care'), a Coordination Action under FP7 (grant 261469) and the European Society of Human Genetics.</s><s>GSD is supported by the AO Foundation start-up-grant (S-12-27S) and The Leducq Foundation, The International FOP Association (IFOPA), the Isaac and Rose Nassau Professorship of Orthopaedic Molecular Medicine, the Cali-Weldon Professorship of FOP Research and the National Institute's of Health (R01-AR41916).</s></p></div>
			</div>

			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Classic and atypical fibrodysplasia ossificans progressiva (FOP) phenotypes are caused by mutations in the bone morphogenetic protein (BMP) type I receptor ACVR1</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">S</forename><surname>Kaplan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Seemann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Connor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">L</forename><surname>Glaser</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Carroll</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hum Mutat</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="page" from="379" to="390" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">M</forename><surname>Shore</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">J</forename><surname>Feldman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Fenstermacher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">J</forename><surname>Cho</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">H</forename><surname>Choi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Genet</title>
		<imprint>
			<biblScope unit="volume">38</biblScope>
			<biblScope unit="page" from="525" to="527" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">The FOP metamorphogene encodes a novel type I receptor that dysregulates BMP signaling</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">S</forename><surname>Kaplan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Pignolo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">M</forename><surname>Shore</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cytokine Growth Factor Rev</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page" from="399" to="407" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<author>
			<persName><forename type="first">J</forename><surname>Haupt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Deichsel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Stange</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Ast</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Bocciardi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Ravazzolo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">ACVR1 p.Q207E causes classic fibrodysplasia ossificans progressiva and is functionally distinct from the engineered constitutively active ACVR1 p.Q207D variant</title>
				<imprint>
			<date type="published" when="2014">2014</date>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page" from="5364" to="5377" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Fibrodysplasia ossificans progressiva: clinical and genetic aspects</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Pignolo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">M</forename><surname>Shore</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">S</forename><surname>Kaplan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Orphanet J Rare Dis</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page">80</biblScope>
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Inherited human diseases of heterotopic bone formation 72</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">M</forename><surname>Shore</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">S</forename><surname>Kaplan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Rev Rheumatol</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page" from="518" to="527" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Circumscribed myositis ossificans of the masseter muscle: report of a case 1</title>
		<author>
			<persName><forename type="first">P</forename><surname>Piombino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">G</forename><surname>Dell'aversana</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Abbate</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Fini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">M</forename><surname>Liberatore</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Mici</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">G Chir</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="page" from="271" to="274" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Fibrodysplasia ossificans progressiva (FOP): watch the great toes!</title>
		<author>
			<persName><forename type="first">M</forename><surname>Kartal-Kaess</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">M</forename><surname>Shore</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Schwering</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Uhl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Korinthenberg</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur J Pediatr</title>
		<imprint>
			<biblScope unit="volume">169</biblScope>
			<biblScope unit="page" from="1417" to="1421" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Non-hereditary heterotopic ossification. Implications for injury, arthropathy, and aging</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Pignolo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">L</forename><surname>Foley</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Rev Bone Miner Metabol</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page" from="261" to="266" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Diagnostic and mutational spectrum of progressive osseous heteroplasia (POH) and other forms of GNAS-based heterotopic ossification</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">S</forename><surname>Adegbite</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">S</forename><surname>Kaplan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">M</forename><surname>Shore</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Pignolo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Med Genet A</title>
		<imprint>
			<biblScope unit="volume">146</biblScope>
			<biblScope unit="page" from="1788" to="1796" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Late-onset variant fibrodysplasia ossificans progressiva leading to misdiagnosis of ankylosing spondylitis</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">P</forename><surname>Barnett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Dugar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Haan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Med Genet A</title>
		<imprint>
			<biblScope unit="volume">155</biblScope>
			<biblScope unit="page" from="1492" to="1495" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Fibrodysplasia ossificans progressiva in two half-sisters: evidence for maternal mosaicism</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">B</forename><surname>Janoff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Muenke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Johnson</forename><surname>Lo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Rosenberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">M</forename><surname>Shore</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Okereke</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Med Genet</title>
		<imprint>
			<biblScope unit="volume">61</biblScope>
			<biblScope unit="page" from="320" to="324" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Investigations of activated ACVR1/ALK2, a bone morphogenetic protein type I receptor, that causes fibrodysplasia ossificans progressiva</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">S</forename><surname>Kaplan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Seemann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Haupt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">Y</forename><surname>Lounev</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mullins</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Methods Enzymol</title>
		<imprint>
			<biblScope unit="volume">484</biblScope>
			<biblScope unit="page" from="357" to="373" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Early diagnosis of fibrodysplasia ossificans progressiva</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">S</forename><surname>Kaplan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">L</forename><surname>Glaser</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Collins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Connor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Kitterman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Pediatrics</title>
		<imprint>
			<biblScope unit="volume">121</biblScope>
			<biblScope unit="page" from="e1295" to="e1300" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Iatrogenic harm caused by diagnostic errors in fibrodysplasia ossificans progressiva</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Kitterman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kantanie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Rocke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">S</forename><surname>Kaplan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Pediatrics</title>
		<imprint>
			<biblScope unit="volume">116</biblScope>
			<biblScope unit="page" from="e654" to="e661" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Fibrodysplasia ossificans progressiva: diagnosis, management, and therapeutic horizons</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Pignolo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">M</forename><surname>Shore</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">S</forename><surname>Kaplan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Pediatr Endocrinol Rev</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="437" to="448" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note>Suppl</note>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Early mortality and cardiorespiratory failure in patients with fibrodysplasia ossificans progressiva</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">S</forename><surname>Kaplan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Zasloff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Kitterman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">M</forename><surname>Shore</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">C</forename><surname>Hong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Rocke</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Bone Joint Surg Am</title>
		<imprint>
			<biblScope unit="volume">92</biblScope>
			<biblScope unit="page" from="686" to="691" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Fibrodysplasia ossificans progressiva. The clinical features and natural history of 34 patients</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Connor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Evans</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Bone Joint Surg Br</title>
		<imprint>
			<biblScope unit="volume">64</biblScope>
			<biblScope unit="page" from="76" to="83" />
			<date type="published" when="1982">1982</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">The natural history of heterotopic ossification in patients who have fibrodysplasia ossificans progressiva. A study of forty-four patients</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Cohen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">V</forename><surname>Hahn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Tabas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Peeper</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">L</forename><surname>Levitz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Sando</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Bone Joint Surg Am</title>
		<imprint>
			<biblScope unit="volume">75</biblScope>
			<biblScope unit="page" from="215" to="219" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Genetic transmission of fibrodysplasia ossificans progressiva</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">S</forename><surname>Kaplan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Mccluskey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Hahn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Tabas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Muenke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Zasloff</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Bone Joint Surg Am</title>
		<imprint>
			<biblScope unit="volume">75</biblScope>
			<biblScope unit="page" from="1214" to="1220" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
	<note>Report of a family</note>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
